ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01014052
Recruitment Status : Completed
First Posted : November 16, 2009
Last Update Posted : May 14, 2013
Sponsor:
Information provided by (Responsible Party):
QLT Inc.